AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (7.6 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Research Article | Open Access

Manganese mineralization based stromal depleter priming nanomedicine penetration for robust cancer therapy

Yunyang Zhang1,2,§, Siying Chen1,2,§, Yuxin Wang1,2,§, Jingjing Zhang1,2, Xinyan Yang3, Haoran Li1,2, Hongxia Dai1,2, Shibo Wang1,2, M. Zubair Iqbal1,2, Yao Li1,2, Xiangdong Kong1,2 ( ), Ruibo Zhao1,2 ( )
Institute for Smart Biomedical Materials, School of Materials Science & Engineering, Zhejiang Sci-Tech University, Hangzhou 310008, China
Zhejiang-Mauritius Joint Research Center for Biomaterials and Tissue Engineering, Zhejiang Sci-Tech University, Hangzhou 310018, China
School of Laboratory Medicine and Bioengineering, Zhejiang Provincial People’s Hospital (Affiliated People’s Hospital), Hangzhou Medical College, Hangzhou 311399, China

§ Yunyang Zhang, Siying Chen, and Yuxin Wang contributed equally to this work.

Show Author Information

Abstract

Poor tumor penetration is a significant challenge for using nanoliposome-based chemotherapy for triple-negative breast cancer (TNBC). Recently, a milieu of biological cues downregulating tumor stroma has been associated with biological metal ions, primarily such as Mn2+. Inspired by this, we hypothesized that Mn2+ could serve as a functional component in designing an alternative modulator for the tumor stroma microenvironment by reducing its extracellular matrix, further decreasing its stromal density. Herein, we presented a novel extracellular matrix (ECM) depleter within a tumor involving manganese-based mineralization materials that primed inhibition of the extracellular matrix of cancer cells, demonstrating a facile strategy for improving drug penetration, delivery and therapy efficiency of the doxorubicin-loaded liposome nanoparticles (Dox-LNP). As a result, the manganese mimetic mineralization material, manganese phosphate (MnP), demonstrated controlled biodegradation and biocompatibility within tumor microenvironments. The release of Mn2+ from MnP within the cell lysosome or tumor microenvironment inhibited TGF-β expression and its downstream profibrotic signaling pathways, thereby reducing the tumor stroma density by suppressing the expression of α-smooth actin (α-SMA) and collagen I (COL-I), and inducing tumor stromal disruption both in vitro and in vivo. The typical nanomedicines, Dox-LNP, were subsequently used to check their penetration. The MnP pretreated tumor could significantly improve tumor penetration and accumulation of Dox-LNP, which demonstrated a significant improvement in the treatment of TNBC. These achievements proposed a successful tumor stromal regulation material involving manganese mineralization for priming tumor stromal depletion in situ by inhibiting the TGF-β and associated proteins, representing an alternative materials strategy to substitute biotechnology for stromal reduction, which may further represent a great potential of nanomedicine-based cancer therapy.

Graphical Abstract

This study presents an innovative tumor extracellular matrix depleter using manganese mineralization to modulate TGF-β/SMAD pathways, aiming to reduce matrix barriers surrounding cancer cells and improve doxorubicin-loaded liposome nanoparticles (Dox-LNPs) penetration, boosting its efficacy against triple-negative breast cancer.

Electronic Supplementary Material

Download File(s)
8058_ESM.pdf (1.1 MB)

References

【1】
【1】
 
 
Nano Research
Article number: 94908058

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
Zhang Y, Chen S, Wang Y, et al. Manganese mineralization based stromal depleter priming nanomedicine penetration for robust cancer therapy. Nano Research, 2026, 19(1): 94908058. https://doi.org/10.26599/NR.2025.94908058
Topics:

2204

Views

388

Downloads

5

Crossref

5

Web of Science

4

Scopus

0

CSCD

Received: 11 June 2025
Revised: 08 September 2025
Accepted: 09 September 2025
Published: 26 December 2025
© The Author(s) 2026. Published by Tsinghua University Press.

This is an open access article under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0, https://creativecommons.org/licenses/by/4.0/).